Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neuromuscular disorders]

Umbertina C Reed1

  • 1Universidade de São Paulo, São Paulo, SP, Brazil.

Jornal De Pediatria
|December 17, 2003
PubMed
Summary
This summary is machine-generated.

This review details key diagnostic factors for childhood neuromuscular disorders affecting motor neurons, nerves, and muscles. Advances in molecular genetics now offer improved diagnosis and classification of these conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Congenital myasthenic syndrome: Correlation between clinical features and molecular diagnosis.

European journal of neurology·2021
Same author

Dominant or recessive mutations in the <i>RYR1</i> gene causing central core myopathy in Brazilian patients.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2021
Same author

Real-World Data from Nusinersen Treatment for Patients with Later-Onset Spinal Muscular Atrophy: A Single Center Experience.

Journal of neuromuscular diseases·2020
Same author

Reply to "Global Central Nervous System Atrophy in Spinal Muscular Atrophy Type 0".

Annals of neurology·2019
Same author

Clinical and molecular findings in a cohort of ANO5-related myopathy.

Annals of clinical and translational neurology·2019
Same author

Severe brain involvement in 5q spinal muscular atrophy type 0.

Annals of neurology·2019
Same journal

Acetaminophen versus Ibuprofen for the management of hemodynamically significant patent ductus arteriosus in very low birth weight infants: randomized trial.

Jornal de pediatria·2026
Same journal

Cross-cultural adaptation into Brazilian Portuguese of an international questionnaire for the assessment of cardiopulmonary resuscitation knowledge among adolescents.

Jornal de pediatria·2026
Same journal

Evaluation of ChatGPT's reliability in answering questions about short stature and growth failure.

Jornal de pediatria·2026
Same journal

Validity of the Khamis-Roche method, relative to bone age, in Portuguese children and adolescents from 11 to 15 years.

Jornal de pediatria·2026
Same journal

Urogenital congenital anomalies in children under 9 years: global disease burden analysis and projections, 1990-2021.

Jornal de pediatria·2026
Same journal

Intraventricular hemorrhage in preterm newborns: a multicenter study in four Brazilian hospitals.

Jornal de pediatria·2026
See all related articles

Area of Science:

  • Pediatrics
  • Neurology
  • Genetics

Background:

  • Childhood neuromuscular disorders affect motor neurons, peripheral nerves, neuromuscular junctions, and muscle fibers.
  • Accurate differential diagnosis is crucial for timely and effective management.
  • Distinguishing primary neuromuscular conditions from secondary hypotonia due to CNS or systemic issues is essential.

Purpose of the Study:

  • To outline critical aspects for the differential diagnosis of major pediatric neuromuscular disorders.
  • To provide a clinical approach for differentiating various neuromuscular conditions.
  • To highlight the importance of considering secondary causes of hypotonia.

Main Methods:

  • Clinical experience over 12 years with pediatric neuromuscular disorder patients.

Related Experiment Videos

  • Literature review of Medline database and the journal Neuromuscular Disorders.
  • Analysis of clinical features guiding differential diagnosis.

    • Main Results:

    • Most pediatric neuromuscular disorders are genetic.
    • Common conditions include Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Congenital Muscular Dystrophy, Myotonic Dystrophy, and Congenital Myopathies.
    • Molecular genetics advancements have significantly clarified pathogenesis.

    Conclusions:

    • Significant progress in human molecular genetics has elucidated the pathogenesis of numerous pediatric neuromuscular disorders.
    • New diagnostic tools, including fetal diagnosis, are available.
    • Improved genotype-phenotype correlations and classification systems are now established.